Literature DB >> 26430918

Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.

Anand Prakash Singh1, Saima Aijaz1.   

Abstract

Enteropathogenic E. coli (EPEC) cause diarrhea and are the major cause of mortality in developing countries. EPEC use a type III secretion system to deliver effector proteins into the host epithelial cells. To understand the functions of these effectors, majority of studies on EPEC pathogenesis have relied on infections of animals or cell lines with wild type strains of EPEC or mutant strains deficient in one or more effectors. While these studies have provided valuable data, it can be difficult to assess functions of an individual effector in the presence of other EPEC effectors. Recent studies have reported the use of transient transfections with plasmids encoding various EPEC effectors into different cell lines. However, variable transfection efficiencies and expression levels of the effector proteins coupled with their expression for relatively short periods of time pose a problem if the long term effects of these effectors need to be examined. We have generated a MDCK cell line with constitutive expression of the EPEC effector Map (Mitochondrial associated protein) for efficient stable expression of EGFP-tagged Map. We observed that the constitutive expression of Map increased the permeability of charged and non-charged molecules. We also generated polyclonal antibodies against Map and checked for their specificity in MDCK-Map expressing cells. Map has been reported to contribute to the onset of diarrhea but the underlying mechanism is yet to be identified. The MDCK-Map cell line and the anti-Map antibodies generated by us can be used for in vitro studies to examine the role of Map in EPEC pathogenesis.

Entities:  

Keywords:  MDCK; enteropathogenic E coli; mitochondrial associated protein; tight junctions

Mesh:

Substances:

Year:  2015        PMID: 26430918      PMCID: PMC4825835          DOI: 10.1080/21655979.2015.1096456

Source DB:  PubMed          Journal:  Bioengineered        ISSN: 2165-5979            Impact factor:   3.269


  26 in total

1.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.

Authors:  I Simonovic; J Rosenberg; A Koutsouris; G Hecht
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

Review 3.  Molecular physiology and pathophysiology of tight junctions V. assault of the tight junction by enteric pathogens.

Authors:  C L Sears
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-12       Impact factor: 4.052

Review 4.  Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Authors:  Lila G Glotfelty; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

Review 5.  Dynamics and functions of tight junctions.

Authors:  Emily Steed; Maria S Balda; Karl Matter
Journal:  Trends Cell Biol       Date:  2010-01-12       Impact factor: 20.808

6.  Characterization of an established line of canine kidney cells (MDCK).

Authors:  C R Gaush; W L Hard; T F Smith
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

Review 7.  Exploitation of host cells by enteropathogenic Escherichia coli.

Authors:  B A Vallance; B B Finlay
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 8.  In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections.

Authors:  Robyn J Law; Lihi Gur-Arie; Ilan Rosenshine; B Brett Finlay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli.

Authors:  Ajitha Thanabalasuriar; Athanasia Koutsouris; Andrew Weflen; Mark Mimee; Gail Hecht; Samantha Gruenheid
Journal:  Cell Microbiol       Date:  2009-08-27       Impact factor: 3.715

10.  Insights into the pathogenesis of enteropathogenic E. coli using an improved intestinal enterocyte model.

Authors:  Paul Dean; Lorna Young; Sabine Quitard; Brendan Kenny
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

View more
  5 in total

1.  EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Cell Microbiol       Date:  2017-07-27       Impact factor: 3.715

Review 2.  Modulation of epithelial cell polarity by bacterial pathogens.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Ann N Y Acad Sci       Date:  2017-06-19       Impact factor: 5.691

3.  A strategy design based on antibiotic‑resistance and plasmid replicons genes of clinical Escherichia coli strains.

Authors:  Junyan Liu; Xin Lin; Thanapop Soteyome; Yanrui Ye; Dingqiang Chen; Ling Yang; Zhenbo Xu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

4.  Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation.

Authors:  Anand Prakash Singh; Swati Sharma; Kirti Pagarware; Rafay Anwar Siraji; Imran Ansari; Anupam Mandal; Pangertoshi Walling; Saima Aijaz
Journal:  Sci Rep       Date:  2018-02-27       Impact factor: 4.379

5.  Enteropathogenic Escherichia coli (EPEC) Recruitment of PAR Polarity Protein Atypical PKCζ to Pedestals and Cell-Cell Contacts Precedes Disruption of Tight Junctions in Intestinal Epithelial Cells.

Authors:  Rocio Tapia; Sarah E Kralicek; Gail A Hecht
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.